发明名称 MODIFIED RELEASE DOSAGE FORMS
摘要 A dosage form comprises: (a) at least one active ingredient; (b) a core; and(c) a shell which surrounds the core, wherein the shell is substantially free of pores having a diameter of 0.5-5.0 microns, and the shell comprises a first shell portion and a second shell portion which are compositionally different and the dosage form provides a modified release profile of the active ingredient upon contacting of the dosage form with a liquid medium. In another embodiment, the dosage form comprises: (a) at least one active ingredient; (b) a core comprising first and second core portions; and (c) a shell which surrounds the core, wherein the shell comprises first and second shell portions such that the first shell portion resides upon the first core portion and the second shell portion resides upon the second core portion, and at least one of the first or second shell portions or first or second shell portions provides a modified release profile of the active ingredient upon contacting of the dosage form with a liquid medium.
申请公布号 WO03026625(A1) 申请公布日期 2003.04.03
申请号 WO2002US31024 申请日期 2002.09.28
申请人 MCNEIL-PPC, INC.;LEE, DER-YANG;LI, SHUN-POR;MCTEIGUE, DANIEL;PARIKH, NARENDRA;SOWDEN, HENRY, S.;THOMAS, MARTIN;WYNN, DAVID 发明人 LEE, DER-YANG;LI, SHUN-POR;MCTEIGUE, DANIEL;PARIKH, NARENDRA;SOWDEN, HENRY, S.;THOMAS, MARTIN;WYNN, DAVID
分类号 A23G3/34;A23G1/00;A23G1/54;A23G3/00;A23G3/04;A23G3/36;A23G3/54;A23L1/00;A23L1/09;A23L1/30;A61J3/00;A61J3/06;A61J3/10;A61K9/00;A61K9/14;A61K9/20;A61K9/22;A61K9/24;A61K9/26;A61K9/28;A61K9/30;A61K9/32;A61K9/34;A61K9/36;A61K9/38;A61K9/48;A61K9/50;A61K31/136;A61K31/137;A61K31/277;A61K47/10;A61K47/14;A61K47/26;A61K47/30;A61K47/32;A61K47/34;A61K47/36;A61K47/38;A61K47/44;A61K47/46;A61P11/00;B30B11/08;B30B11/34;B30B15/30;G06F17/30 主分类号 A23G3/34
代理机构 代理人
主权项
地址